Asia R.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
- Adjuvant Pembrolizumab Versus Capecitabine or Olaparib in Patients with Early-Stage Triple-Negative Breast Cancer with Residual Disease Following Neoadjuvant Therapy
- Evaluation of CDK4/6 Inhibitors Abemaciclib, Palbociclib, and Ribociclib in HR+/HER2- Metastatic Breast Cancer: A Randomized Clinical Trial
- Phase IIb Randomized Trial of Carboplatin-Cyclophosphamide vs. Paclitaxel ± Atezolizumab in Advanced Triple Negative Breast Cancer
Data & Insights
Has run more than one trial at 63 of 70 partner sites.
Specializations
Thoracic Oncology
Clinical interest is centered on non-small cell lung cancer, including EGFR-mutated, KRAS G12C-mutated, RET fusion-positive, and MET-driven disease, with additional involvement in small-cell lung cancer and early-stage resected or unresectable lung malignancies.
- Advanced non-small cell lung cancer
- EGFR exon 19del and exon 21 L858R disease
- KRAS G12C-positive lung cancer
- Limited-stage small-cell lung cancer
Research activity also extends to perioperative and locally advanced settings, reflecting a strong focus on treatment innovation across lung cancer subtypes.
Breast and Gynecologic Oncology
Therapeutic involvement includes breast cancer, especially HER2-positive, hormone receptor-positive, and triple-negative breast cancer, alongside vulvar high-grade squamous intraepithelial lesion and related female-oncology care.
- Metastatic breast cancer
- HER2-positive breast cancer
- Triple-negative breast cancer
- Vulvar HSIL
Interest in these areas highlights a commitment to refining systemic and adjuvant approaches for malignancies affecting women.
Hematologic Malignancies
Research work covers chronic lymphocytic leukemia, small lymphocytic lymphoma, diffuse large B-cell lymphoma, and multiple myeloma, with attention to both frontline and relapsed disease settings.
- Chronic lymphocytic leukemia
- Small lymphocytic lymphoma
- Diffuse large B-cell lymphoma
- Multiple myeloma
The portfolio also includes studies linked to treatment adaptation and supportive care in blood cancers.
Cardiovascular and Renal Medicine
Clinical trial involvement spans atherosclerotic cardiovascular disease, acute coronary syndrome, myocardial infarction, heart failure, chronic kidney disease, and lipid disorders, with interest in prevention of major cardiovascular events.
- Atherosclerotic cardiovascular disease
- Heart failure prevention
- Chronic kidney disease
- Elevated lipoprotein(a)
These activities connect cardiometabolic risk reduction with renal protection and long-term vascular disease management.
Inflammatory and Respiratory Disorders
Additional therapeutic focus includes rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, polymyalgia rheumatica, severe asthma, chronic obstructive pulmonary disease, and refractory chronic cough.
- Inflammatory rheumatic diseases
- Severe eosinophilic asthma
- Chronic obstructive pulmonary disease
- Refractory chronic cough
This area reflects involvement in immune-mediated disease control and respiratory symptom management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.